Medical Developments International Limited (ASX:MVP)

Market Cap	65.91M
Revenue (ttm)	39.06M
Net Income (ttm)	94.00K
Shares Out	112.66M
EPS (ttm)	0.00
PE Ratio	701.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	392,236
Average Volume	174,023
Open	0.5800
Previous Close	0.5800
Day's Range	0.5500 - 0.5850
52-Week Range	0.3950 - 0.9400
Beta	1.49
RSI	40.44
Earnings Date	Aug 26, 2025

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP